Genmab Provided Earnings Guidance for Year 2022. For the year, company expects its revenue to be in the range of DKK 13,500 million – DKK 14,500 million, an increase to the previous guidance of DKK 12,000 million – DKK 13,000 million and expects operating profit to be in the range of DKK 5,100 million – DKK 6,500 million, an increase to the previous guidance of DKK 3,800 million – DKK 5,400 million, driven primarily by the items described above.